Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports 3 Months Standalone Results
Company Name : Egyptian International Pharmaceuticals (EIPICO)
ISIN Code : EGS38081C013
Currency : EGP
F/S Standalone Period : From 01/01/2024 To 31/03/2024
Net Profit : 626,144,137
F/S Standalone Period : From 01/01/2023 To 31/03/2023
Net Comparative Profit : 182,646,912
Audit Status : Reviewed
Source : Egyptian International Pharmaceuticals (EIPICO)
The BoD Report in Arabic (311 KB)
The BoD Report in English (1,915 KB)
ISIN Code : EGS38081C013
Currency : EGP
F/S Standalone Period : From 01/01/2024 To 31/03/2024
Net Profit : 626,144,137
F/S Standalone Period : From 01/01/2023 To 31/03/2023
Net Comparative Profit : 182,646,912
Audit Status : Reviewed
Source : Egyptian International Pharmaceuticals (EIPICO)
The BoD Report in Arabic (311 KB)
The BoD Report in English (1,915 KB)
Comments